Product
AST-201
1 clinical trial
1 indication
Indication
Ovarian CancerClinical trial
A Randomized Phase 2 Study to Evaluate the Efficacy and Safety for Adjuvant Therapeutic Cancer Vaccine (AST-201, pUMVC3-hIGFBP-2) in Patients With Advanced Ovarian Cancer (Cornerstone-004)Status: Not yet recruiting, Estimated PCD: 2025-11-15